Ripple kopen? Dit zijn de mogelijkheden

Acrux Aandeel

0,13USD 0,01USD 6,27%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Acrux LtdShs - Profiel

Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. It operates through the following geographical segments: Australia, Switzerland, United States, and Other. Its products brands include AXIRON, ELLAVIE & EVAMIST and RECUVYRA. The company was founded by Ross Dobinson and Barrie Charles Finnin in 1998 and is headquartered in West Melbourne, Australia.

Aandeelhouder

Eigenaar in %
Freefloat1,00
Government Pension Fund - Global (the)0,01
Vanguard Total International Stock Index Fund0,01
John Hancock Ii - International Small Company Fund0,00
Simon Green, PhD0,00

Adres

103-113 Stanley Street, 3003 West Melbourne
Postbus:
Telefoon: 61.3.8379.0100
Fax: 61.3.8379.0101
Internet: http://www.acrux.com.au

Management

Michael Kotsanis
Chief Executive Officer, Director & MD
Deborah Ambrosini
Chief Financial Officer & Secretary
Nina Webster
Commercial Director
Felicia Colagrande
Director-Technical Affairs & Product Development
Geoff E. D. Brooke
Independent Non-Executive Director
Simon Green
Independent Non-Executive Director
Timothy Oldham
Independent Non-Executive Director
Ross Dobinson
Non-Executive Chairman

Invoer toevoegen